Attendees of the 3rd Grand Rounds U.S. met a “who’s who” of the biopharma industry, including executives, investors and innovators from companies such as:

  • 5AM Ventures
  • A-Alpha Bio
  • Alexandria Real Estate Equities
  • Allen Institute
  • Alnair Therapeutics
  • Amazon Web Services
  • Astellas Venture Management
  • AUTM
  • Biocom
  • BrainXell Therapeutics
  • Callio Therapeutics
  • Charles River Laboratories
  • Chicago Biomedical Consortium (CBC)
  • Chugai Pharmaceutical
  • Cooley
  • Critical Path Initiative
  • Deerfield Management
  • Eisai Innovation
  • ESC Advisors
  • Evotec
  • Flagship Pioneering
  • Frazier Life Sciences
  • Fred Hutchinson Cancer Center
  • Gates Foundation
  • GV (Google Ventures)
  • Illinois Economic Development Corporation
  • Institute for Protein Design
  • Institute for Systems Biology
  • inThought Research
  • IQIVA
  • Jeito Capital
  • Johnson & Johnson
  • J.P. Morgan
  • Judo Bio
  • KdT Ventures
  • Life Science Washington
  • Lumira Ventures
  • Madrona Venture Group
  • MPM BioImpact
  • National Institutes of Health (NIH)
  • nChroma Bio
  • Novartis
  • o2h Ventures
  • Ono Venture Investment
  • Parker Institute for Cancer Immunology
  • Persephoni Bio
  • Pfizer
  • Phase Capital
  • Roche Diagnostics
  • Samsara Biocapital
  • Seattle Children's Research Institute
  • Sofinnova Investments
  • Solid Biosciences
  • Sutro Biopharma
  • Takeda Pharmaceuticals
  • Texas Medical Center
  • TMC Venture Fund
  • Twist BioScience
  • Ubuntu Research
  • Umoja Biopharma
  • University of Washington
  • Vancouver Island Life Sciences Association (VILS)
  • Variant Bio
  • Vie Ventures
  • Washington Research Foundation (WRF)
  • Wilson Hill Ventures
  • WuXi Biologics
  • WuXi XDC
  • Xontogeny
  • And many more…